These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 29849523

  • 1. Bromelain-based enzymatic debridement and minimal invasive modality (mim) care of deeply burned hands.
    Krieger Y, Rubin G, Schulz A, Rosenberg N, Levi A, Singer AJ, Rosenberg L, Shoham Y.
    Ann Burns Fire Disasters; 2017 Sep 30; 30(3):198-204. PubMed ID: 29849523
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Our initial learning curve in the enzymatic debridement of severely burned hands-Management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm.
    Schulz A, Perbix W, Shoham Y, Daali S, Charalampaki C, Fuchs PC, Schiefer J.
    Burns; 2017 Mar 30; 43(2):326-336. PubMed ID: 28341257
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity.
    Fischer S, Haug V, Diehm Y, Rhodius P, Cordts T, Schmidt VJ, Kotsougiani D, Horter J, Kneser U, Hirche C.
    Surgery; 2019 Jun 30; 165(6):1100-1105. PubMed ID: 30678870
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M, Haik J, Cleary M, Vashurin I, Aviv U, Kornhaber R.
    Isr Med Assoc J; 2020 Feb 30; 22(2):83-88. PubMed ID: 32043324
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: An European consensus.
    Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez JR, Monstrey S, Murray A, Plock JA, Sander F, Schulz A, Ziegler B, Kneser U.
    Burns; 2017 Dec 30; 43(8):1640-1653. PubMed ID: 29033046
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enzymatic debridement: past, present, and future.
    De Decker I, De Graeve L, Hoeksema H, Monstrey S, Verbelen J, De Coninck P, Vanlerberghe E, Claes KEY.
    Acta Chir Belg; 2022 Aug 30; 122(4):279-295. PubMed ID: 35440290
    [Abstract] [Full Text] [Related]

  • 18. Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes.
    Shoham Y, Gasteratos K, Singer AJ, Krieger Y, Silberstein E, Goverman J.
    Int Wound J; 2023 Dec 30; 20(10):4364-4383. PubMed ID: 37455553
    [Abstract] [Full Text] [Related]

  • 19. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
    Singer AJ, McClain SA, Taira BR, Rooney J, Steinhauff N, Rosenberg L.
    J Burn Care Res; 2010 Dec 30; 31(2):304-9. PubMed ID: 20182376
    [Abstract] [Full Text] [Related]

  • 20. Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds.
    Giudice G, Filoni A, Maggio G, Bonamonte D, Vestita M.
    Biomed Res Int; 2017 Dec 30; 2017():9567498. PubMed ID: 28293640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.